Personalized Kinase Inhibitor Therapy Combined With Chemotherapy in Treating Patients With Newly Diagnosed Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
Conditions
- Acute Lymphoblastic Leukemia
- Acute Myeloid Leukemia
Interventions
- DRUG: Cyclophosphamide
- DRUG: Cytarabine
- DRUG: Dasatinib
- DRUG: Dexamethasone
- DRUG: Doxorubicin Hydrochloride
- DRUG: Idarubicin
- DRUG: Idelalisib
- DEVICE: In Vitro Kinase Inhibitor Assay
- DRUG: Leucovorin Calcium
- DRUG: Methotrexate
- DRUG: Methylprednisolone Sodium Succinate
- DRUG: Ponatinib Hydrochloride
- BIOLOGICAL: Rituximab
- DRUG: Ruxolitinib Phosphate
- DRUG: Sorafenib Tosylate
- DRUG: Sunitinib Malate
- DRUG: Vincristine Sulfate
Sponsor
OHSU Knight Cancer Institute
Collaborators